REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Stada Baltics (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: UAB Stada Baltics Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Stada Baltics operates as a pharmaceutical company responsible for the marketing and distribution of branded generics, consumer healthcare and specialty pharmaceutical products across the Baltic region. The company manages product portfolios that include prescription medicines, over-the-counter drugs and health products aligned with the STADA Group's international offering. Geographic scope covers Lithuania and neighboring Baltic markets. Key assets include regulatory approvals, product registrations and access to STADA's global pharmaceutical portfolio. Strategic positioning focuses on expanding access to affordable medicines and strengthening market presence in consumer healthcare and generics.

Headquarters
A. Gostauto g. 40A
Vilnius; Vilnius county; Postal Code: LT-03163

Contact Details: Purchase the UAB Stada Baltics report to view the information.

Website: https://www.stada.lt/

Basic Information
Total Employees:
Purchase the UAB Stada Baltics report to view the information.
Registered Capital:
Purchase the UAB Stada Baltics report to view the information.
Financial Auditors:
Purchase the UAB Stada Baltics report to view the information.
Incorporation Date:
May 24, 2005
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Stada Baltics report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
42.06%
Total operating revenue
42.06%
Net Profit (Loss) for the Period
102.01%
Total Equity
93.27%
Net Profit Margin
3.9%
Return on Equity (ROE)
2.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?